ES2127529T3 - Emulsiones mucoadhesivas que contienen ciclodextrina. - Google Patents

Emulsiones mucoadhesivas que contienen ciclodextrina.

Info

Publication number
ES2127529T3
ES2127529T3 ES95919433T ES95919433T ES2127529T3 ES 2127529 T3 ES2127529 T3 ES 2127529T3 ES 95919433 T ES95919433 T ES 95919433T ES 95919433 T ES95919433 T ES 95919433T ES 2127529 T3 ES2127529 T3 ES 2127529T3
Authority
ES
Spain
Prior art keywords
emulsions containing
containing cyclodextrin
mucoadhesive
mucoadhesive emulsions
cyclodextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95919433T
Other languages
English (en)
Inventor
Peter Putteman
Marc Karel Jozef Francois
Eric Carolus Leonarda Snoeckx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2127529T3 publication Critical patent/ES2127529T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Materials For Medical Uses (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL USO DE UNA CICLODEXTRINA O DERIVADO DE LA MISMA COMO MUCOADHESIVO EN UNA EMULSION O SOLUCION ACUOSA, DICHA CICLODEXTRINA O DERIVADO DE LA MISMA SE USA EN UNA CANTIDAD DE UN 10% A UN 70% DE PESO TENIENDO EN CUENTA EL PESO TOTAL DE LA COMPOSICION.
ES95919433T 1994-05-18 1995-05-10 Emulsiones mucoadhesivas que contienen ciclodextrina. Expired - Lifetime ES2127529T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94201402 1994-05-18

Publications (1)

Publication Number Publication Date
ES2127529T3 true ES2127529T3 (es) 1999-04-16

Family

ID=8216883

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95919433T Expired - Lifetime ES2127529T3 (es) 1994-05-18 1995-05-10 Emulsiones mucoadhesivas que contienen ciclodextrina.

Country Status (29)

Country Link
US (1) US5814330A (es)
EP (1) EP0759741B1 (es)
JP (1) JP3862748B2 (es)
KR (1) KR100369703B1 (es)
CN (1) CN1091590C (es)
AP (1) AP731A (es)
AT (1) ATE174790T1 (es)
AU (1) AU680767B2 (es)
BG (1) BG62754B1 (es)
BR (1) BR9507873A (es)
CZ (1) CZ285606B6 (es)
DE (1) DE69506857T2 (es)
DK (1) DK0759741T3 (es)
EE (1) EE03304B1 (es)
ES (1) ES2127529T3 (es)
FI (1) FI964589L (es)
HU (1) HU218082B (es)
IL (1) IL113742A (es)
MY (1) MY113846A (es)
NO (1) NO309507B1 (es)
NZ (1) NZ285761A (es)
OA (1) OA10321A (es)
PL (1) PL179619B1 (es)
RO (1) RO117145B1 (es)
RU (1) RU2164418C2 (es)
SK (1) SK282623B6 (es)
TW (1) TW438601B (es)
WO (1) WO1995031178A1 (es)
ZA (1) ZA954023B (es)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000503527A (ja) * 1995-11-28 2000-03-28 ザ ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン 条件付き複製ウイルスベクターおよびその用途
IL129569A (en) * 1996-10-24 2004-06-01 Procter & Gamble A water preparation absorbs odor and a process for its production
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
KR19990001564A (ko) * 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
DE69808670T2 (de) 1997-12-31 2003-07-03 Choongwae Pharma Corp., Seoul/Soul Herstellungsverfahren und zusammensetzung einer oralen zubereitung von itraconazol
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
GB9920167D0 (en) * 1999-08-25 1999-10-27 Avery Dennison Corp Pressure sensitive adhesive compositions
WO2001034213A1 (en) * 1999-11-09 2001-05-17 The Procter & Gamble Company Cyclodextrin compositions for odor, insect and dust mite contol
US6835717B2 (en) 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
KR100388605B1 (ko) * 2000-06-13 2003-06-25 코오롱제약주식회사 용해도 및 용해속도가 향상된 이트라코나졸의 액상 조성물 및 이를 이용한 이트라코나졸 제제와 그 제조방법
US20020013331A1 (en) 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
DK1997478T3 (da) 2001-02-15 2013-12-09 Access Pharma Inc Flydende formuleringer til forebyggelse og behandling af slimhindesygdomme og -lidelser
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US8563592B2 (en) 2001-11-01 2013-10-22 Spectrum Pharmaceuticals, Inc. Bladder cancer treatment and methods
ES2384208T3 (es) * 2001-11-01 2012-07-02 Spectrum Pharmaceuticals, Inc. Composiciones medicinales para el tratatamiento intravesical del cáncer de vejiga.
CN101259289B (zh) * 2001-11-02 2012-05-30 嵌入治疗公司 用于rna干扰的治疗用途的方法及组合物
US20030144362A1 (en) * 2002-01-28 2003-07-31 Utterberg David S. High viscosity antibacterials for cannulae
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
RU2225612C2 (ru) * 2002-04-30 2004-03-10 Уфимский научно-исследовательский институт медицины труда и экологии человека Способ прогнозирования течения множественной миеломы
US6824763B2 (en) 2002-05-30 2004-11-30 Kimberly-Clark Worldwide, Inc. Anti-fungal powder having enhanced excipient properties
US7977532B2 (en) 2002-09-05 2011-07-12 The Procter & Gamble Company Tampon with clean appearance post use
WO2005027807A1 (en) * 2003-09-19 2005-03-31 Drugtech Corporation Pharmaceutical delivery system
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
US20060024372A1 (en) * 2004-07-29 2006-02-02 Utterberg David S High viscosity antibacterials
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20090227690A1 (en) * 2004-09-27 2009-09-10 Cargill, Incorporated Cyclodextrin Inclusion Complexes and Methods of Preparing Same
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
JP2008523101A (ja) 2004-12-10 2008-07-03 タリマ セラピューティクス， インコーポレイテッド 爪ユニットの状態を治療するための組成物および方法
CA2605341A1 (en) * 2005-05-09 2006-11-16 Drugtech Corporation Modified-release pharmaceutical compositions
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
WO2007079389A2 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
EP1968544A2 (en) * 2006-01-05 2008-09-17 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
DK3354276T3 (da) 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
US20090131386A1 (en) * 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
KR101449785B1 (ko) 2008-04-21 2014-10-14 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
EP2306975A4 (en) 2008-07-21 2012-10-31 Otonomy Inc COMPOSITIONS WITH A TAXED RELEASE FOR MODULATING THE EARM STRUCTURE AND THE BORN IMMUNE SYSTEM, AND METHODS OF TREATING EAR OR DISEASE
US8784870B2 (en) * 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
CA2734763C (en) 2008-08-20 2016-06-28 Ranjan Dohil Corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
CN105377355A (zh) 2013-03-14 2016-03-02 拇趾公司 治疗甲单元的感染、疾病或病症的方法
BR112018001900A2 (pt) 2015-07-28 2018-09-18 Otonomy, Inc. composições agonistas de trkb ou trkc e métodos para o tratamento de condições óticas
JP7033789B2 (ja) 2016-06-29 2022-03-11 オトノミー，インク． トリグリセリド耳用製剤とその使用
AU2019207704B2 (en) 2018-01-09 2024-05-02 Dompé Farmaceutici S.P.A. Growth factor otic formulations
WO2019154895A1 (en) 2018-02-08 2019-08-15 Strekin Ag Gel formulation for preventing or treating hearing loss

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
ES2058503T5 (es) * 1988-03-29 1999-04-16 Univ Florida Formulaciones farmaceuticas para uso parenteral.
US5055303A (en) * 1989-01-31 1991-10-08 Kv Pharmaceutical Company Solid controlled release bioadherent emulsions
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
CA2129828A1 (en) * 1992-02-12 1993-08-19 Giovanni Lucchetti Liposomal itraconazole formulations
DE69330248T2 (de) * 1992-03-18 2002-03-21 Janssen Pharmaceutica N.V., Beerse Itraconazol- und saperconazolstereoisomere
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
FR2719999B1 (fr) * 1994-05-17 1996-08-02 Georges Serge Grimberg Composition pharmaceutique à base de gomme de guar et d'un antiacide neutralisant, à laquelle peut être ajoutée une série de principes actifs thérapeutiques.

Also Published As

Publication number Publication date
CN1091590C (zh) 2002-10-02
HU218082B (hu) 2000-05-28
AP731A (en) 1999-02-08
NO309507B1 (no) 2001-02-12
EE03304B1 (et) 2000-12-15
HU9603188D0 (en) 1997-01-28
CN1148335A (zh) 1997-04-23
PL179619B1 (pl) 2000-10-31
KR100369703B1 (ko) 2003-04-16
DK0759741T3 (da) 1999-08-23
NZ285761A (en) 1997-05-26
DE69506857T2 (de) 1999-08-05
CZ285606B6 (cs) 1999-09-15
IL113742A0 (en) 1995-08-31
TW438601B (en) 2001-06-07
RU2164418C2 (ru) 2001-03-27
AP9600873A0 (en) 1996-10-31
EP0759741B1 (en) 1998-12-23
FI964589A0 (fi) 1996-11-15
DE69506857D1 (de) 1999-02-04
AU680767B2 (en) 1997-08-07
RO117145B1 (ro) 2001-11-30
US5814330A (en) 1998-09-29
BG62754B1 (bg) 2000-07-31
HUT76326A (en) 1997-08-28
BG100955A (bg) 1998-04-30
ATE174790T1 (de) 1999-01-15
FI964589A7 (fi) 1996-11-15
AU2526495A (en) 1995-12-05
IL113742A (en) 1999-09-22
OA10321A (en) 1997-10-07
PL317257A1 (en) 1997-04-01
KR970702719A (ko) 1997-06-10
HK1010688A1 (en) 1999-06-25
SK282623B6 (sk) 2002-10-08
JPH10500121A (ja) 1998-01-06
EP0759741A1 (en) 1997-03-05
WO1995031178A1 (en) 1995-11-23
FI964589L (fi) 1996-11-15
NO964853L (no) 1996-11-15
SK146996A3 (en) 1997-05-07
MY113846A (en) 2002-06-29
NO964853D0 (no) 1996-11-15
BR9507873A (pt) 1997-09-23
JP3862748B2 (ja) 2006-12-27
CZ336996A3 (en) 1997-02-12
ZA954023B (en) 1996-11-18

Similar Documents

Publication Publication Date Title
ES2127529T3 (es) Emulsiones mucoadhesivas que contienen ciclodextrina.
MXPA02007822A (es) Composicion cosmetica, especialmente para el uso en piel envejecida y/o tensa.
KR870006891A (ko) 구강 위생 조성물
ES2107762T3 (es) Utilizacion de un alquilester de glutation en una composicion cosmetica o dermatologica destinada al tratamiento por via topica del envejecimiento cutaneo.
ES2105551T3 (es) Utilizacion de derivados de la resorcina substituidos en posicion(es) 4,4 y 5 o 4 y 6 en unas composiciones cosmeticas o dermofarmaceuticas con accion despigmentante.
ES2095057T3 (es) Dispersiones o disoluciones que contienen compuestos de hidroxilamina como agentes de reticulacion.
PL369008A1 (en) Microbiocidal formulation comprising essential oils or their derivatives
DE69918408D1 (de) Durchsichtige riechstoff-zusammensetzung
ES2102159T3 (es) Barniz para uñas acuoso, incoloro o coloreado, que contiene un polimero filmogeno en estado dispersado y un compuesto perfluoroalquilo hidrosoluble.
ES2115754T3 (es) Nuevos 19-nor-esteroides que tienen en posicion 11beta una cadena tiocarbonada, su procedimiento de preparacion y los productos intermedios de este procedimiento, su aplicacion como medicamentos y composiciones.
KR950002588A (ko) 과산화수소 조성물
ES2181501T3 (es) Composicion cosmetica.
ES2187070T3 (es) Composiciones de laca para el cabello autofobas.
ATE233484T1 (de) Desinfizierende zusammensetzung
SE9701301L (sv) Krympreducerande medel för cementkompositioner
ES2189525T3 (es) Composicion perfumada con efecto antisolar y bronceador.
BR0011261A (pt) Composição oral compreendendo perlita, e, uso de perlita
ES2112670T3 (es) Derivados de ciclodextrina y su utilizacion, particularmente en cosmetica.
ES2186191T3 (es) Productos de reaccion del acido fosfonico y su uso en composiciones de recubrimiento.
ATE205386T1 (de) Einphasige,transparente wässrige zusammensetzung
KR950005929A (ko) 탈지방지형 무취 네일 에나멜 리무버 조성물
AR024200A1 (es) Composiciones de barnices acrilicos fotopolimerizables que contienen un agente antioxidante de la familia de los fenoles estericamente impedidos.
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
MX9605659A (es) Emulsiones mucoadhesivas que contienen ciclodextrina.
ES2069960T3 (es) Agente o concentrado para la conservacion de madera y materiales de madera.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 759741

Country of ref document: ES